Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) shares in Thousands, $ in Millions	Total	Common Stock	Exchangeable Shares	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Redeemable Convertible Preferred Stock	Series A Redeemable Convertible Preferred Stock
Temporary equity, beginning balance (in shares) at Dec. 31, 2021							167,302
Temporary equity, beginning balance at Dec. 31, 2021							$ 2,822
Temporary equity, ending balance (in shares) at Mar. 31, 2022							167,302
Temporary equity, ending balance at Mar. 31, 2022							$ 2,822
Common stock, beginning balance (in shares) at Dec. 31, 2021		69,535
Beginning balance at Dec. 31, 2021	$ (573)	$ 0	$ 0	$ 833	$ (1)	$ (1,405)
Exchangeable share, beginning balance (in shares) at Dec. 31, 2021			689
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)		54
Exercise of common stock options	1			1
Exercise of non-voting common stock warrants (in shares)		1,858
Exercise of non-voting common stock warrants	34			34
Issuance of common stock in connection with subscription agreement and initial public offering, net of underwriting discounts and offering costs (in shares)		465
Stock-based compensation	7			7
Foreign currency translation adjustments	4				4
Net unrealized gain (loss) on available-for-sale marketable securities, net of tax	(2)				(2)
Net income (loss)	(82)					(82)
Common stock, ending balance (in shares) at Mar. 31, 2022		71,912
Exchangeable share, ending balance (in shares) at Mar. 31, 2022			689
Ending balance at Mar. 31, 2022	(611)	$ 0	$ 0	875	1	(1,487)
Temporary equity, beginning balance (in shares) at Dec. 31, 2021							167,302
Temporary equity, beginning balance at Dec. 31, 2021							$ 2,822
Temporary equity, ending balance (in shares) at Sep. 30, 2022							167,302
Temporary equity, ending balance at Sep. 30, 2022							$ 2,822
Common stock, beginning balance (in shares) at Dec. 31, 2021		69,535
Beginning balance at Dec. 31, 2021	(573)	$ 0	$ 0	833	(1)	(1,405)
Exchangeable share, beginning balance (in shares) at Dec. 31, 2021			689
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Foreign currency translation adjustments	(7)
Net unrealized gain (loss) on available-for-sale marketable securities, net of tax	(3)
Net income (loss)	(38)
Common stock, ending balance (in shares) at Sep. 30, 2022		72,205
Exchangeable share, ending balance (in shares) at Sep. 30, 2022			689
Ending balance at Sep. 30, 2022	(563)	$ 0	$ 0	891	(11)	(1,443)
Temporary equity, beginning balance (in shares) at Mar. 31, 2022							167,302
Temporary equity, beginning balance at Mar. 31, 2022							$ 2,822
Temporary equity, ending balance (in shares) at Jun. 30, 2022							167,302
Temporary equity, ending balance at Jun. 30, 2022							$ 2,822
Common stock, beginning balance (in shares) at Mar. 31, 2022		71,912
Beginning balance at Mar. 31, 2022	(611)	$ 0	$ 0	875	1	(1,487)
Exchangeable share, beginning balance (in shares) at Mar. 31, 2022			689
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)		31
Stock-based compensation	6			6
Foreign currency translation adjustments	(5)				(5)
Net unrealized gain (loss) on available-for-sale marketable securities, net of tax	(1)				(1)
Net income (loss)	8					8
Common stock, ending balance (in shares) at Jun. 30, 2022		71,943
Exchangeable share, ending balance (in shares) at Jun. 30, 2022			689
Ending balance at Jun. 30, 2022	(603)	$ 0	$ 0	881	(5)	(1,479)
Temporary equity, ending balance (in shares) at Sep. 30, 2022							167,302
Temporary equity, ending balance at Sep. 30, 2022							$ 2,822
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)		39
Stock-based compensation	10			10
Issuance of restricted stock in connection with business acquisitions (in shares)		223
Foreign currency translation adjustments	(6)				(6)
Net unrealized gain (loss) on available-for-sale marketable securities, net of tax	0
Net income (loss)	36					36
Common stock, ending balance (in shares) at Sep. 30, 2022		72,205
Exchangeable share, ending balance (in shares) at Sep. 30, 2022			689
Ending balance at Sep. 30, 2022	$ (563)	$ 0	$ 0	891	(11)	(1,443)
Temporary equity, beginning balance (in shares) at Dec. 31, 2022	167,302						167,302	0
Temporary equity, beginning balance at Dec. 31, 2022	$ 2,822						$ 2,822	$ 0
Temporary equity, ending balance (in shares) at Mar. 31, 2023							167,302
Temporary equity, ending balance at Mar. 31, 2023							$ 2,822
Common stock, beginning balance (in shares) at Dec. 31, 2022	72,230	72,230
Beginning balance at Dec. 31, 2022	$ (64)	$ 0	$ 0	918	(5)	(977)
Exchangeable share, beginning balance (in shares) at Dec. 31, 2022	689		689
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)		98
Issuance of non-voting common stock upon settlement of restricted stock units (in shares)		46
Non-voting common stock withheld for tax obligation and net settlement (in shares)		(23)
Common stock withheld or cancelled for tax obligation and net settlement (in shares)		23
Stock-based compensation	$ 5			5
Foreign currency translation adjustments	(1)				(1)
Net unrealized gain (loss) on available-for-sale marketable securities, net of tax	2				2
Net income (loss)	128					128
Common stock, ending balance (in shares) at Mar. 31, 2023		72,351
Exchangeable share, ending balance (in shares) at Mar. 31, 2023			689
Ending balance at Mar. 31, 2023	$ 70	$ 0	$ 0	923	(4)	(849)
Temporary equity, beginning balance (in shares) at Dec. 31, 2022	167,302						167,302	0
Temporary equity, beginning balance at Dec. 31, 2022	$ 2,822						$ 2,822	$ 0
Temporary equity, ending balance (in shares) at Sep. 30, 2023							0	5,833
Temporary equity, ending balance at Sep. 30, 2023							$ 0	$ 175
Common stock, beginning balance (in shares) at Dec. 31, 2022	72,230	72,230
Beginning balance at Dec. 31, 2022	$ (64)	$ 0	$ 0	918	(5)	(977)
Exchangeable share, beginning balance (in shares) at Dec. 31, 2022	689		689
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)	10,033
Foreign currency translation adjustments	$ 1
Net unrealized gain (loss) on available-for-sale marketable securities, net of tax	2
Net income (loss)	$ (1,757)
Common stock, ending balance (in shares) at Sep. 30, 2023	280,087	280,087
Exchangeable share, ending balance (in shares) at Sep. 30, 2023	0		0
Ending balance at Sep. 30, 2023	$ 3,484	$ 0	$ 0	6,220	(2)	(2,734)
Temporary equity, beginning balance (in shares) at Mar. 31, 2023							167,302
Temporary equity, beginning balance at Mar. 31, 2023							$ 2,822
Temporary equity, ending balance (in shares) at Jun. 30, 2023							167,302	0
Temporary equity, ending balance at Jun. 30, 2023							$ 2,822	$ 0
Common stock, beginning balance (in shares) at Mar. 31, 2023		72,351
Beginning balance at Mar. 31, 2023	70	$ 0	$ 0	923	(4)	(849)
Exchangeable share, beginning balance (in shares) at Mar. 31, 2023			689
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)		25
Stock-based compensation	5			5
Foreign currency translation adjustments	2				2
Net income (loss)	114					114
Common stock, ending balance (in shares) at Jun. 30, 2023		72,376
Exchangeable share, ending balance (in shares) at Jun. 30, 2023			689
Ending balance at Jun. 30, 2023	191	$ 0	$ 0	928	(2)	(735)
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares)							(167,302)
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering							$ (2,822)
Issuance of Series A redeemable convertible preferred stock, net of issuance costs (in shares)								5,833
Issuance of Series A redeemable convertible preferred stock								$ 175
Temporary equity, ending balance (in shares) at Sep. 30, 2023							0	5,833
Temporary equity, ending balance at Sep. 30, 2023							$ 0	$ 175
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)		9,910
Exercise of common stock options	3			3
Issuance of common stock in connection with subscription agreement and initial public offering, net of underwriting discounts and offering costs (in shares)		14,100
Issuance of common stock in connection with initial public offering, net of underwriting discounts and offering costs	392			392
Non-voting common stock withheld for tax obligation and net settlement (in shares)		25,398
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares)		167,692
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering	2,822			2,822
Conversion of exchangeable shares to common stock in connection with initial public offering (in shares)		688	(688)
Forfeiture of exchangeable shares (in shares)			(1)
Issuance of common stock upon settlement of restricted stock units (in shares)		33,288
Exercise of common stock warrants (in shares)		7,431
Common stock withheld or cancelled for tax obligation and net settlement (in shares)		(25,398)
Common stock withheld or cancelled for tax obligation and net settlement	(570)			(570)
Stock-based compensation	2,645			2,645
Foreign currency translation adjustments	0
Net unrealized gain (loss) on available-for-sale marketable securities, net of tax	0
Net income (loss)	$ (1,999)					(1,999)
Common stock, ending balance (in shares) at Sep. 30, 2023	280,087	280,087
Exchangeable share, ending balance (in shares) at Sep. 30, 2023	0		0
Ending balance at Sep. 30, 2023	$ 3,484	$ 0	$ 0	$ 6,220	$ (2)	$ (2,734)